Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 9, 2002, Pages 1247-1249

  Nakano, Daisuke ^a   Itoh, Chie ^a   Takaoka, Masanori ^a   Kiso, Yoshinobu ^b   Tanaka, Takaharu ^b   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Deoxycorticosterone acetate (DOCA) salt hypertension; Sesamin; Superoxide

Indexed keywords

ANTIHYPERTENSIVE AGENT; SESAMIN; SUPEROXIDE; 1,3 DIOXOLANE DERIVATIVE; LIGNAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; METABOLISM; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; DIOXOLES; HYPERTENSION; LIGNANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 0036729015     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1247     Document Type: Article

References (16)

1. Matsumura Y., Kita S., Morimoto S., Akimoto S., Furuya M., Oka N., Tanaka T., Biol. Pharm. Bull., 1016-1019 (1995).
2. Kita S., Matsumura Y., Morimoto S., Akimoto K., Furuya M., Oka N., Tanaka T., Biol. Pharm. Bull., 18, 1283-1285 (1995).
3. Matsumura Y., Kita S., Tanida Y., Taguchi Y., Morimoto S., Akimoto S., Tanaka T., Biol. Pharm. Bull., 21, 469-473 (1998).
4. Matsumura Y., Kita S., Ohgushi R., Okui T., Biol. Pharm. Bull., 23, 1041-1045 (2000).
5. Shimizu S., Akimoto K., Shinmen Y., Kawashima H., Sugano M., Yamada H., Lipids, 26, 512-516 (1991).
6. Hirose N., Inoue T., Nishihara K., Sugano M., Akimoto K., Shimizu S., Yamada H., J. Lipid Res., 32, 629-638 (1991).
7. Akimoto K., Kitagawa Y., Akamatsu T., Hirose N., Sugano M., Shimizu S., Yamada H., Ann. Nutr. Metab., 37, 218-224 (1993).
8. Hirose N., Doi F., Ueki T., Akazawa K., Chijiiwa K., Sugano M., Akimoto K., Shimizu S., Yamada H., Anticancer Res., 12, 1259-1266 (1992).
9. Chen X., Touyz R. M., Park J. B., Schiffrin E. L., Hypertension, 38, 606-611 (2001).
10. Aizawa T., Ishizaka N., Usui S., Ohashi N., Ohno M., Nagai R., Hypertension, 39, 149- 154 (2002).
11. Fukuda Y., Nagata T., Osawa T., Namiki M., J. Am. Oil Chem. Soc., 63, 1027-1031 (1986).
12. Skatchkov M. P., Sperling D., Hink U., Mülsch A., Harrison D. G., Sindermann I., Meinertz T., Münzel T., Biochem. Biophys. Res. Commun., 254, 319- 324 (1999).
13. Asami S., Akimoto K., Abe K., Akamatsu T., Konishi K., Shimizu S., Sugano M., Yamada H., Nippon Nogeikagaku Kaishi, 67, 265 (1993) (abstract).
14. Griendling K. K., Sorescu D., Ushio-Fukai M., Circ. Res., 86, 494-501 (2000).
15. Beswick R. A., Dorrance A. M., Leite R., Webb C., Hypertension, 38, 1107-1111 (2001).
16. Hishikawa K., Oemar B. S., Yang Z., Luscher T. F., Circ. Res., 81, 797-803 (1997).